Form 4: Ironwood Pharmaceuticals Director Catherine Moukheibir Sells Shares

Director Catherine Moukheibir sold shares of Ironwood Pharmaceuticals (IRWD) on June 6th and 7th, 2024.

Summary

• Catherine Moukheibir, a director of Ironwood Pharmaceuticals, sold shares of the company's Class A Common Stock on June 6th and 7th, 2024.
• On June 6th, 44,426 shares were sold at a weighted average price of $6.36, with prices ranging from $6.30 to $6.43.
• Following this transaction, the director beneficially owned 84,207 shares.
• On June 7th, an additional 35,574 shares were sold at a weighted average price of $6.61, with prices ranging from $6.56 to $6.65.
• After this second transaction, the director's beneficial ownership decreased to 48,633 shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock sales by a director. It doesn't inherently convey positive or negative sentiment, but insider sales can sometimes be interpreted negatively by the market.

Industry Context

This filing is a routine disclosure of stock sales by a company insider. It's common for directors and officers to periodically sell shares for personal financial management.

Stakeholder Impact

• The stock sale by a director could have a minor impact on shareholder sentiment.

Key Dates